06-AUG-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 1153 11 574 89 1084 168 1023
ERLYTX 84 0 0 5 61 14 85
GI 167 1 52 10 122 24 146
GU 347 4 209 33 402 71 432
LEUK 162 3 157 15 183 38 231
LUNG 209 5 261 21 256 41 250
LYMPH 427 6 313 39 475 70 426
MELAN 28 0 0 0 0 0 0
MMYEL 117 1 52 11 134 18 110
MULT 51 1 52 5 61 11 67
OTHER 54 0 0 3 37 7 43
Total 2799 32 1670 231 2815 462 2813

06-AUG-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
  1 0 0 1 12 1 6
CCD 187 4 209 21 256 42 256
ERLYTX 5 0 0 0 0 1 6
GU 5 0 0 1 12 1 6
LEUK 623 11 574 54 657 95 578
LUNG 381 6 313 33 402 53 323
MELAN 3 0 0 3 37 3 18
OTHER 11 0 0 0 0 1 6
PEOLC 93 0 0 4 49 6 37
PREV 243 0 0 11 134 37 225
SXQOL 661 10 522 73 889 108 657
Total 2213 31 1618 201 2448 348 2118

06-AUG-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
  1 0 0 1 12 1 6
BREAST 1153 11 574 89 1084 168 1023
CCD 187 4 209 21 256 42 256
ERLYTX 89 0 0 5 61 15 91
GI 167 1 52 10 122 24 146
GU 352 4 209 34 414 72 438
LEUK 785 14 730 69 840 133 810
LUNG 590 11 574 54 657 94 572
LYMPH 427 6 313 39 475 70 426
MELAN 31 0 0 3 37 3 18
MMYEL 117 1 52 11 134 18 110
MULT 51 1 52 5 61 11 67
OTHER 65 0 0 3 37 8 49
PEOLC 93 0 0 4 49 6 37
PREV 243 0 0 11 134 37 225
SXQOL 661 10 522 73 889 108 657
Total 5012 63 3287 432 5262 810 4931

06-AUG-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 714 3 157 52 633 98 597
ERLYTX 57 0 0 5 61 11 67
GI 126 1 52 9 110 19 116
GU 266 3 157 25 304 52 317
LEUK 99 1 52 9 110 23 140
LUNG 130 5 261 15 183 24 146
LYMPH 277 3 157 24 292 45 274
MELAN 18 0 0 0 0 0 0
MMYEL 67 1 52 9 110 12 73
MULT 20 0 0 2 24 5 30
OTHER 54 0 0 3 37 7 43
Total 1828 17 888 153 1864 296 1803

06-AUG-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
  1 0 0 1 12 1 6
CCD 139 2 104 12 146 26 158
ERLYTX 5 0 0 0 0 1 6
GU 5 0 0 1 12 1 6
LEUK 265 6 313 24 292 37 225
LUNG 233 5 261 23 280 36 219
MELAN 3 0 0 3 37 3 18
OTHER 11 0 0 0 0 1 6
PEOLC 72 0 0 4 49 6 37
PREV 243 0 0 11 134 37 225
SXQOL 486 7 365 55 670 79 481
Total 1463 20 1043 134 1632 228 1387

06-AUG-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
  1 0 0 1 12 1 6
BREAST 891 5 261 71 864 132 804
CCD 162 3 157 10 122 23 140
ERLYTX 62 0 0 5 61 12 73
GI 133 2 104 9 110 22 134
GU 303 5 261 32 390 56 341
LEUK 366 8 417 34 414 61 371
LUNG 385 8 417 40 487 64 390
LYMPH 277 3 157 24 292 45 274
MELAN 21 0 0 3 37 3 18
MMYEL 67 1 52 9 110 12 73
MULT 41 0 0 4 49 5 30
OTHER 156 0 0 4 49 9 55
PEOLC 71 1 52 4 49 7 43
PREV 243 0 0 11 134 37 225
SXQOL 486 7 365 55 670 79 481
Total 3665 43 2243 316 3850 568 3458

06-AUG-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES COORDINATED BY SWOG

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 979 11 574 84 1023 156 950
ERLYTX 79 0 0 5 61 14 85
GI 99 1 52 4 49 14 85
GU 247 3 157 24 292 52 317
LEUK 132 3 157 14 170 34 207
LUNG 183 4 209 18 219 37 225
LYMPH 355 4 209 31 377 53 323
MMYEL 102 1 52 8 97 15 91
MULT 51 1 52 5 61 11 67
Total 2227 28 1462 193 2349 386 2350

06-AUG-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

Inst. Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
Member 1918 19 991 154 1875 296 1802
AFFIL 141 0 0 7 85 16 97
CCOP/NCORP 1232 18 939 126 1534 212 1291
Non-SWOG 1721 26 1357 145 1765 286 1741
Total 5012 63 3287 432 5259 810 4931

06-AUG-2026 6:11

STUDIES OPENED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
LEUK MM1OA-S04 MyeloMATCH: AML, ASTX727 + Ven (28D v 14D) 1 Y 22-JUL-26
ERLYTX S2505 Sarcoma, Stg II-IIIB, Surg + Short vs Std RT 1 Y 06-JUL-26
LUNG S1900N AGAs: SG alone, I alone, or SG + I 1 Y 03-AUG-26

06-AUG-2026 6:11

STUDIES CLOSED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
GI S1922 Small Bowel,Ram+Pac vs FOLFIRI, mets/unresect 1 N 15-JUL-26
ERLYTX S2012 Extrapulm NEC, Stg IV, Combo Chemo +/- Atezo 1 T 09-JUL-26
SXQOL NRGCC011 Breast, Survivors, Cog Training 0 E 03-AUG-26
SXQOL NRGCC011 Breast, Survivors, Cog Training 1 E 03-AUG-26

06-AUG-2026 6:11

STUDIES WITH 3 OR MORE REGISTRATIONS THIS WEEK

ADMIN STUDYID STNAME REGTYPE Registrations
LEUK MYELOMATCH MSRP for the NCI myeloMATCH Clinical Trials 1 11
BREAST S2212 Breast, TNBC, Neoadj Chemo + Pembro 1 11
LUNG LUNGMAP NSCLC, Adv, Master 2 8
BREAST S2206 Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva 1 7
LUNG LUNGMAP NSCLC, Adv, Master 1 6
SXQOL S2013 I-CHECKIT: ICI toxicity risk prediction study 1 6
SXQOL S2205 ICE COMPRESS: Reduction of CIPN from Taxanes 1 4
CCD S2417CD Colrec Surv, Follow-up w/ CTAC site 1 4
GU S1802 Pros, Stg IV, SST ± Surg/RT to Primary Tum 2 3
LYMPH S2308 FL, LTB, Mosunetuzumab vs Rituximab 1 3